ResearcherChina Pharmaceutical UniversityNo recent work listed
Hongbao Yang
Matched on ORCID iD 0000-0002-6902-7311; OpenAlex author ID A5030832384. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper
Papers 4
- Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing. Last author DOI 10.3389/fimmu.2023.1133166↗
- Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5. Co-author DOI 10.1002/jbt.23192↗
- Identification of Molecular Targets and Underlying Mechanisms of Xiaoji Recipe against Pancreatic Cancer Based on Network Pharmacology. Co-author DOI 10.1155/2022/4640849↗
- STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation. Co-author DOI 10.3389/fonc.2020.594224↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cunbing Xia · 2 shared papers, 2022–2023 · strength 0.36
- Percy David Papa Akuetteh · 2 shared papers, 2020–2022 · strength 0.26
- Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
- Paper STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53… DOI 10.3389/fonc.2020.594224↗
- Qiyu Zhang · 2 shared papers, 2020–2022 · strength 0.26
- Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
- Paper STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53… DOI 10.3389/fonc.2020.594224↗
- Yang Chen · 1 shared paper, 2023 · strength 0.22
- Dong Xu · 1 shared paper, 2023 · strength 0.22
- Fugen Shangguan · 1 shared paper, 2022 · strength 0.15
- Shijia Wu · 1 shared paper, 2022 · strength 0.15
- Huimin Huang · 1 shared paper, 2022 · strength 0.15
- Guihua Jin · 1 shared paper, 2022 · strength 0.15
- Linhua Lan · 1 shared paper, 2022 · strength 0.15
- Hong Zhu · 1 shared paper, 2022 · strength 0.14
- Yongkang Zhu · 1 shared paper, 2022 · strength 0.14
- Dong Xu · 1 shared paper, 2022 · strength 0.14
- Wenqian Huang · 1 shared paper, 2020 · strength 0.11
- Chenlei Zheng · 1 shared paper, 2020 · strength 0.11
- Keqing Shi · 1 shared paper, 2020 · strength 0.11
- Bicheng Chen · 1 shared paper, 2020 · strength 0.11
- Shanshan Hu · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.